Microchip Reports Q4 EPS $0.11, Sales $970.5M, Raises Q1 FY26 Guidance; Insulet Posts Q1 EPS $1.02, Revenue $569M on Omnipod 5 Expansion

Microchip Technology Inc. reported its fiscal fourth-quarter earnings with an adjusted EPS of $0.11, slightly above the estimated $0.10, and net sales of $970.5 million, surpassing the expected $962.7 million. The company provided guidance for the first quarter of fiscal 2026, anticipating adjusted EPS between $0.18 and $0.26, and net sales ranging from $1.02 billion to $1.07 billion, both above market estimates. Microchip also declared a quarterly dividend of $0.455 per share, unchanged from previous payments. The positive earnings and optimistic outlook contributed to a premarket stock increase of over 9%. Meanwhile, Insulet Corporation reported strong first-quarter fiscal 2025 results with an adjusted EPS of $1.02 and revenue of $569 million, driven by global expansion of its Omnipod 5 system and 29% revenue growth. Insulet raised its full-year 2025 guidance following these results. The company’s shares surged more than 12% in premarket trading and continued to rise, reaching gains of up to 39.45%. Other notable stock market gainers included Tesla, ON Semiconductor, and Solventum Corp.